表 3. Levels of BALP, PINP and β-CTX in patients with stage 3-5 CKD.
CKD 3~5期患者的BALP、PINP和β-CTX水平
Group | n | BALP/(U/L) | PINP/(ng/mL) | β-CTX/(ng/mL) |
*P<0.05, vs. control group; #P<0.05, vs. CKD stage 3 group;▲P<0.05, vs. CKD stage 4 group. | ||||
Control | 60 | 35.74±5.70 | 37.38±5.13 | 0.25±0.04 |
CKD stage 3 | 38 | 78.95±11.49* | 52.24±7.22* | 0.42±0.06* |
CKD stage 4 | 42 | 94.63±12.87*,# | 61.78±7.86*,# | 0.67±0.08*,# |
CKD stage 5 without dialysis | 59 | 137.51±19.34*,#,▲ | 79.43±8.54*,#,▲ | 1.28±0.18*,#,▲ |
CKD stage 5 hemodialysis | 229 | 143.62±21.55*,#,▲ | 81.34±8.80*,#,▲ | 1.34±0.17*,#,▲ |
t | 592.832 | 441.569 | 884.495 | |
P | <0.001 | <0.001 | <0.001 |